14/02/26 14:38:06.75
In one very recent development, a Riken insider told Bioscience Technology this week that first author Obokata received an email from a scientist claiming to have repeated her results. Other success “anecdotes” have accumulated, the insider emailed.
But the insider warned, given many anecdotal reports of failure, it is key to stay “agnostic.”